Sukhtian Ghiath M. (CIK 1717441) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-01). Recent activity: Buy OTLK (8.5M shares), Buy OTLK (4.3M shares), Buy OTLK (3.5M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-01 | Outlook Therapeutics, Inc. (OTLK) | Director | Buy | 8.5M | $5.0M |
| 2025-05-28 | Outlook Therapeutics, Inc. (OTLK) | Director | Buy | 4.3M | $6.0M |
| 2025-03-12 | Outlook Therapeutics, Inc. (OTLK) | Director | Buy | 3.5M | $8.7M |
Source: SEC Form 4 filings · as of 2026-06-01